To investigate whether novel insight features in new Blood Glucose Monitoring System (BGMs) can improve glycemic control.

Inclusion Criteria Summary:

• Diagnosed with Type 1 diabetes mellitus or Type 2 diabetes mellitus for ≥ 3 month prior to screening
• Currently performing self-monitoring of blood glucose (SMBG) at home for diabetes management decisions
• Willingness to notify the study staff if they become pregnant during the study
• Willing to sign an informed consent

Exclusion Criteria Summary:

• Currently using a continuous or flash glucose monitoring
• Currently pregnant or planning pregnancy within duration of study or breast feeding; subjects who become pregnant during the study will be withdrawn.
• Conflict of Interest

Device being used in the study is CE marked and will be used as intended therefore risk is minimal. What? Individual participant data that underlie the results reported in publications, after deidentification (text, tables, figures, and appendices).

When? Beginning 9 months and ending 36 months following article publication. With whom? Investigators whose proposed use of the data has been approved by an independent review committee identified for this purpose. For individual participant data meta-analysis. By what mechanism will data be made available? Proposals may be submitted up to 36 months following article publication. After 36 months the data will be available from our archive but without investigator support other than deposited metadata. Information regarding submitting proposals and accessing data may be found by reaching out to the study contact listed. What other documents will be available?Abbreviated CSR may be provided upon request and assessment by the company.

Up to 12 months post study completion.

Investigators whose proposed use of the data has been approved by an independent review committee identified for this purpose.